Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study

BACKGROUND: After liver transplantation (LT), nonadherence to immunosuppressants due to the complex regimen can lead to graft rejection and loss. This study assessed the efficacy and safety of conversion from twice-daily tacrolimus (Bid-Tac) to once-daily prolonged-release tacrolimus (OD-Tac) in liv...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Transplant
Huvudupphovsmän: Lee, Eung Chang, Kim, Seong Hoon, Park, Sang-Jae
Materialtyp: Artigo
Språk:Inglês
Publicerad: International Scientific Literature, Inc. 2018
Ämnen:
Original Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248274/
https://ncbi.nlm.nih.gov/pubmed/30310047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.910618
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk